This paper is in the following e-collection/theme issue:

mHealth for Wellness, Behavior Change and Prevention (2681) Mobile Health (mhealth) (2679) Depression and Mood Disorders; Suicide Prevention (1247) Web-based and Mobile Health Interventions (3008)

Published on in Vol 9, No 7 (2021): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26498, first published .
A Mobile-Based Intervention to Increase Self-esteem in Students With Depressive Symptoms: Randomized Controlled Trial

A Mobile-Based Intervention to Increase Self-esteem in Students With Depressive Symptoms: Randomized Controlled Trial

A Mobile-Based Intervention to Increase Self-esteem in Students With Depressive Symptoms: Randomized Controlled Trial

Authors of this article:

Alina Bruhns1 Author Orcid Image ;   Thies Lüdtke1 Author Orcid Image ;   Steffen Moritz1 Author Orcid Image ;   Lara Bücker1 Author Orcid Image
Article Authors Cited by (22) Tweetations (6) Metrics

    Original Paper

    University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

    Corresponding Author:

    Lara Bücker, PhD

    University Medical Center Hamburg-Eppendorf (UKE)

    Martinistraße 52

    Hamburg, 20251

    Germany

    Phone: 49 40741055868

    Email: l.buecker@uke.de


    Related ArticleThis is a corrected version. See correction statement in: https://mhealth.jmir.org/2022/5/e39448

    Background: Depressive symptoms are one of the most common and ever-increasing mental health problems among students worldwide. Conventional treatment options, particularly psychotherapy, do not reach all students in need of help. Internet- and mobile-based interventions are promising alternatives for narrowing the treatment gap.

    Objective: In the framework of a randomized controlled trial, we aim to investigate the effectiveness, acceptance, and side effects of a self-help smartphone app (MCT & More) based on cognitive behavioral therapy, mindfulness, acceptance and commitment therapy, and metacognitive training in a sample of students with self-reported depressive symptoms. Furthermore, we were interested in examining the influence of treatment expectations and attitudes toward internet- and mobile-based interventions on treatment adherence and effectiveness.

    Methods: A total of 400 students were recruited via open access websites and randomized to either the intervention group (n=200), who received access to the self-help smartphone app MCT & More for a period of 4 weeks, or to a wait-list control group (n=200). The Patient Health Questionnaire-9 (depression) served as the primary outcome parameter, and the Rosenberg Self-esteem Scale (self-esteem) and the global item of the World Health Organization Quality of Life-abbreviated version (quality of life) served as the secondary outcome parameters. The Attitudes Towards Psychological Online Interventions was used to measure attitudes toward internet- and mobile-based interventions. Outcome expectations were assessed using the Patient Questionnaire on Therapy Expectation and Evaluation, and side effects were assessed using the Inventory for Assessing Negative Effects of Psychotherapy.

    Results: Per-protocol (PP), complete-case, and intention-to-treat analyses showed a significantly higher reduction in depressive symptoms (PP: F1,222=3.98; P=.047; d=0.26) and a significantly higher increase in self-esteem (PP: F1,220=8.79; P=.003; d=0.40) in the intervention group than in the wait-list control group. Most participants regularly used the self-help smartphone app (91/120, 75.8%, at least once a week). The more positive the attitude toward internet- and mobile-based interventions (r=0.260; P=.004) and the more positive the outcome expectation (r=0.236; P=.009), the more frequently the self-help smartphone app was used.

    Conclusions: The effectiveness of the self-help smartphone app MCT & More was demonstrated among students with depressive symptoms compared with a wait-list control group. The app could be offered regularly as a low-threshold intervention to enhance students’ health.

    Trial Registration: German Clinical Trials Register DRKS00020941; https://tinyurl.com/pr84w6er

    JMIR Mhealth Uhealth 2021;9(7):e26498

    doi:10.2196/26498

    Keywords

    mHealth; depression; depressive symptoms; students’ mental health; self-help smartphone app; mobile phone; self-esteem 


    Background

    Universities worldwide are confronted with increasing rates of mental health problems among students [1]. In Germany, 15.6% of the university students state that they are currently affected by depressive symptoms (women: 16.9% and men: 14%) [2]. Adjustments to the new living environment (eg, moving away from home and new social environment), expectations of academic performance (eg, final grade in the master’s program), and other stressors resulting from the university program (50% of male and 65% of female students cite their studies as the most common cause of stress) render students particularly vulnerable to developing mental disorders [3]. Mental disorders such as depressive symptoms affect the social and general functioning of students, thereby negatively influencing the course of their study [4] and leading to a deterioration in academic performance. High depression scores among students have been shown to be associated with a low grade point average [5], and depressive symptoms during examination periods predict low future grades [6]. In addition, students with health problems (mental and physical) take long study durations, change their course of study or university more often, and are less likely to have a secure livelihood [4].

    Despite their negative impact on functioning, mental disorders among students often remain undertreated [7]. The treatment gap can be attributed to the lack of available psychotherapy, especially in rural areas [8]; self-stigmatization [9]; fear of being stigmatized by others [10]; the preference to solve the problem independently [8]; fear of having to talk about one’s own problems to a psychotherapist; or the high treatment costs that may arise. Furthermore, depressive symptoms are often not recognized or misinterpreted by primary care physicians [11], leading to reduced help-seeking behavior [12]. Due to the treatment gap, universities are encouraged to initiate help offers that better reach the affected students [2].

    The Potential of Internet-Based Interventions in the Treatment of Depression

    In Germany, virtually all individuals (>99%) aged between 16 and 44 years use the internet [13]. German students belong to the generation of digital natives (confident in using computer technology), so it is assumed that students can easily use internet-based interventions [14]. The benefits of internet-based interventions are, inter alia, the high level of autonomy and privacy. They can be used from any location and are often available free of charge or at a low cost. They are not intended to replace traditional psychotherapy but to expand conventional care [15]. In the last decade, numerous internet-based interventions, especially for the treatment of anxiety disorders and depression, have been developed and tested for their efficacy [16-18]. Systematic reviews and meta-analyses have shown that they can improve mental health problems such as depression, anxiety, and stress among students [14,19,20].

    Internet-based interventions can be categorized as either guided or self-guided. Although guided internet-based interventions are supported by a therapist or a trained person (eg, via frequent email correspondence or telephone support), self-guided ones do not provide additional human support. A recent meta-analysis indicated that guided internet-based interventions show higher effect sizes than self-guided ones (guided: g=0.65 and unguided: g=0.27) [21]. However, self-guided internet-based interventions have the advantage that they can be made available to a broad population requiring few resources (no psychotherapists required, can be used at any time without waiting time, and low costs for users [22]), making self-guided internet-based interventions easier to implement at universities. Studies have shown that guided and unguided internet-based interventions show similar effectiveness in direct comparison (ie, when the same intervention is evaluated as guided and unguided) [23,24].

    Advantages of Mobile-Based Interventions

    Smartphones are the most used technological devices among students on campus [25]. On average, students use their smartphones for approximately 5 hours a day and check their smartphones 28 times daily, which suggests that mobile-based interventions could be highly appealing to students. Mobile-based interventions have already proven to be an effective strategy for improving health-promoting behavior in the general population (eg, physical activity and weight control) [26]. Recent studies have also indicated the effectiveness of self-help smartphone apps in treating depressive symptoms in university students [27,28]. One of the benefits of mobile-based interventions is that smartphones can be accessed almost anytime and are independent of location [29,30]. Therefore, these exercises can be easily integrated into everyday life of students. Furthermore, mobile-based interventions provide the possibility to link users with other forms of support (eg, telephone numbers for acute crises) and to send reminders to the users. By sending reminders, the adherence of the users can be increased in self-guided treatment for anxiety and depression (eg, course completion with reminders: 58% and course completion without reminders: 35%) [31].

    However, not all health care apps adequately protect the sensitive health data of the users (eg, commercialization of app users’ data) [32], and many German-language depression apps show limitations in quality (eg, in functionality, information quality, esthetics, and user involvement) [33]. Therefore, there is a need for high-quality apps, which are being investigated with regard to their benefits and risks [33]. Previous meta-analyses have found small effect sizes (Hedges g=0.22-0.33) [34,35] in reducing depressive symptoms. Furthermore, a recent study suggested that the actual treatment outcome (reduction in depressive symptoms) for mobile-based interventions can be predicted by the expected treatment outcome (usefulness for the patient: B=0.364 and perception of how logical the treatment is: B=0.528) [36].

    Objective of the Study

    The overall goal of the study is to improve the health of students at German universities. The aim of this study is to examine the acceptance and efficacy of the self-help smartphone app MCT & More among German students with depressive symptoms in comparison with a wait-list control group. To our knowledge, little research has been conducted on the effectiveness and acceptance of self-help smartphone apps for students with depressive symptoms (especially in German-speaking countries).

    A previous version of the app was positively evaluated by the users. In a randomized controlled trial (intervention group and wait-list control group) comprising 90 participants with reported depressive symptoms, it was shown that the app was effective in reducing depressive symptoms when used regularly (ie, several times a week, P=.05) app was effective in reducing depressive symptoms when used regularly (ie, several times a week) [37]. It was expected that the use of the self-help smartphone app would lead to a stronger reduction in depressive symptoms and to a higher increase in self-esteem and quality of life in the intervention group than in the wait-list control group after the intervention period. Another novel aspect we aimed to investigate was whether the effect of the app can be predicted by the attitudes toward the internet- and mobile-based interventions and the expected outcome. Moreover, we examined the possible side effects of self-help smartphone apps, which, to our knowledge, have barely been studied to date. Furthermore, an exploratory moderation analysis was conducted to identify possible moderators that affect differential symptom improvement (per-protocol [PP] sample).


    Design

    Two web-based assessments were performed at baseline (t0) and 4 weeks later (t1). All participants provided web-based informed consent at the beginning of the baseline assessment. No personal information was requested at any time, except for an anonymous email address (instructions to create an anonymous email address were given) and a personal codeword (consisting of the first letters of the parents’ names and some figures of their dates of birth). The collected data were anonymized and stored electronically on a password-protected computer. By providing the codeword or the anonymized email address, the data could be deleted at the request of the participants. At the end of the postassessment period, both groups were given access to a self-help manual, as an incentive, to improve emotional problems. As common in web-based trials, blinding of participants was not possible. The study was conducted in accordance with the Declaration of Helsinki. The local psychological ethics committee of the Center for Psychosocial Medicine of the University Medical Center Hamburg-Eppendorf assessed the study project as ethically unobjectionable (approval number: LPEK-0122).

    Participants

    We recruited participants via web-based platforms and forums by posting an invitation to the study with a link to the web-based baseline assessment. At the beginning of the baseline assessment, participants received detailed information about the study’s goals and procedures and were informed about the underlying data protection. An electronic informed consent form was obtained from each participant.

    The following inclusion criteria had to be met: student at a German university (whether the participants were actually students was checked by asking questions about the study system in Germany, which are difficult to answer correctly for nonstudents, eg, “What scoring system is used to measure your academic performance?”), aged at least 18 years, willing to provide informed consent, having access to the internet and a smartphone, having depressive symptoms (measured by Patient Health Questionnaire [PHQ-9], total score>0), willingness to participate in 2 pseudonymous web-based assessments, willingness to use the self-help smartphone app for a period of 4 weeks on one’s own responsibility, willingness to leave an anonymous email address, no acute suicidal tendencies (measured with item 9 of PHQ-9, cut-off>1), and no current or past bipolar or psychotic disorder. Other psychiatric diagnoses were not a criterion for exclusion. Parallel treatments (eg, psychotherapy or pharmacotherapy) could be continued during participation. If the inclusion criteria were not met, the participants were automatically excluded from the web-based assessment. Then, participants were informed about the reason for exclusion and received information about other help-seeking resources, such as telephone numbers for acute crisis.

    Data collection took place in Germany from March 16, 2020 (first baseline assessment) to July 06, 2020 (last postassessment). During this period, Germany experienced the first wave of the COVID-19 pandemic. A total of 246 participants had to be excluded because the inclusion criteria were not met. The final sample consisted of 400 individuals (Figure 1).

    ‎
    Figure 1. Flowchart. CC: complete-case; ITT: intention-to-treat; MCT: metacognitive training; PP: per-protocol.
    View this figure

    Procedure

    At both measurement points (t0 and t1), data were collected using the survey software Qualtrics. Multiple registrations from one device were detected and prevented by the program. In the baseline assessment, sociodemographic and psychopathological data as well as the attitude toward internet- and mobile-based interventions and expected treatment outcomes were assessed. After the 4-week intervention period, all participants were invited via email to participate in the postassessment and were asked to provide their anonymous email address and personal code again to ensure a correct matching of predata and postdata. Afterward, the participants filled out the same psychopathological questionnaires used in the baseline assessment. In addition, the participants were asked about use frequency (“How often have you used the app during the last 4 weeks?”), side effects, and satisfaction with the self-help smartphone app (refer to the Measures section). The study was conducted at Hamburg-Eppendorf University Medical Center (Germany).

    Randomization

    Randomization was performed using Qualtrics survey software after the baseline assessment. The option equal distribution ensured that there was a balanced distribution between the 2 groups. The allocation rule was set to 1:1.

    Sample Size

    The calculation of the sample size for an analysis of covariance (ANCOVA) with 2 groups was performed using G*Power. The results indicated a sample size of 351 participants based on a small effect of f=0.15, with α=.05, and a power of 0.80. Considering a dropout rate of 15%, the final sample should include 413 participants. The calculation is based on the results of a meta-analysis investigating the effectiveness of smartphone app interventions for depression [34].

    Measures

    PHQ-9: Depression Module

    The self-assessment questionnaire PHQ-9 [38] is the depression module of the Patient Health Questionnaire and is used to measure symptoms of major depression according to the Diagnostic and Statistical Manual of Mental Disorders-IV. The symptoms are assessed using 9 items on a 4-point rating scale ranging from not at all (0) to almost daily (3). A total score between 0 and 27 can be calculated. Sum scores of 0-4 indicate none or minimal depressive symptoms, 5-9 indicate mild depressive symptoms, 10-14 indicate moderate depressive symptoms, and 15-27 indicate severe depressive symptoms. The internal consistency ranges from Cronbach α=.86 to .89 [38,39].

    Rosenberg Self-esteem Scale

    The Rosenberg Self-esteem Scale (RSE) is a self-assessment questionnaire presenting 10 statements on self-esteem, which are rated on a 4-point rating scale (1 to 4) from strongly agree to strongly disagree. The total score ranges from 10 to 40 points. High scores indicated high self-esteem. Its internal consistency ranges from Cronbach α=.77 to .88 [40].

    World Health Organization Quality of Life-Abbreviated Version

    In this study, the first item of the World Health Organization Quality of Life-abbreviated version (WHOQOL-BREF; “How would you assess your quality of life?”) with the response options very poor (1) to very good (5) was chosen to measure quality of life. The WHOQOL-BREF [41] is a self-assessment tool with 26 items (4 domains) and represents a short version of the questionnaire World Health Organization Quality of Life-100, which is based on the World Health Organization’s concept of quality of life. All domain scores were fairly to moderately correlated with the global quality of life [42,43]. In a sample of medical students, the internal consistency was Cronbach α=.896 [44].

    Attitude Toward Psychological Online Interventions

    Attitude Toward Psychological Online Interventions (APOI) [45] is a self-assessment tool consisting of 4 dimensions: (1) skepticism and risk perception, (2) trust in therapeutic efficacy, (3) perception of deficits in mechanization, and (4) perception of the advantages of anonymity. The questionnaire consists of 16 items and can be rated on a 5-point rating scale ranging from do not agree at all to fully agree. The total scale ranges from 16 to 80. A high total score indicates a positive attitude. All 4 dimensions were equally weighted. The APOI has an internal consistency of Cronbach α=.77 [45].

    Patient Questionnaire on Therapy Expectation and Evaluation

    The Patient Questionnaire on Therapy Expectation and Evaluation (PATHEV) [46] is a self-assessment questionnaire that measures therapy expectations and consists of 10 items. The instrument covers 3 subscales: (1) hope of improvement, (2) fear of change, and (3) suitability. Ten statements are presented, which are rated on a 5-point rating scale ranging from not correct at all to completely correct. The higher the sum of the subscales, the stronger the hope of improvement, fear of change, and suitability. The total scale ranges from 11 to 55, and the internal consistency ranges from Cronbach α=.73 to .83. The questionnaire was adapted to internet- and mobile-based interventions (eg, “I consider the treatment principle of psychological internet- and mobile-based interventions to be reasonable”).

    Patient Satisfaction (Fragebogen zur Patientenzufriedenheit)

    The instrument Fragebogen zur Patientenzufriedenheit (ZUF-8) [47] is the German version of the Client Satisfaction Questionnaire-8. The self-assessment questionnaire consists of 8 items that are used to assess patient satisfaction with a treatment, such as psychotherapy, in a 1D and global way. The items can be rated on a 4-point rating scale (eg, excellent, good, less good, and bad). A total score (8-32) can be calculated, whereby a high score indicates a high level of satisfaction. The internal consistency ranges from Cronbach α=.87 to .93 [47,48].

    Inventory for Assessing Negative Effects of Psychotherapy

    The Inventory for Assessing Negative Effects of Psychotherapy (INEP) [49] is a German self-assessment tool with 21 items and focuses on the side effects of psychotherapy regarding intrapersonal changes, partnership, stigma and financial worries, family, friends, dependency, and therapeutic relationship. The instrument consists of 2 scales: side effects (scale 1) and therapeutic misbehavior (scale 2). For the first 6 questions, a 7-point rating scale (−3 to +3, bipolar response format) can be used to indicate the extent to which the respective areas of life have developed positively or negatively from the start of the intervention or whether they have remained unchanged. A unipolar response format is used for questions 7-21 to determine whether a negative effect is experienced and with what intensity (0 to +3) it is perceived. A total score can be calculated for items 1-15, reflecting the number of experienced side effects. Furthermore, the intensity of the experienced side effects can be determined by calculating an average score (1-3, where 3 indicates a high intensity of the side effect). The INEP had an internal consistency of Cronbach α=.86 [49]. As no therapeutic relationship could be developed during the use of the self-help smartphone app, items 16-21 were excluded from the assessment. The wording was slightly adapted (self-help app instead of psychotherapy).

    Intervention

    During the 4-week intervention period, the intervention group had free access to the self-help smartphone app MCT & More (Textbox 1), which is primarily intended for individuals with depressive symptoms.

    The basic package of the self-help smartphone app mood comprises 57 short exercises on the following topics: cognitive strategies, communication and interaction, positive activities, and mindfulness and imagination. The program package gambling was developed especially for individuals with gambling problems, and the program package metacognitive training was intended for individuals with psychotic experiences. These program packages are deactivated by default settings but can also be useful for people who are not affected by the addressed symptoms. They can be activated in the app by the users themselves. The exercises take only a few minutes and are designed to be easy to use in the everyday life of students (Figure 2).

    Module descriptions of the MCT & More smartphone app.

    Modules and Their Descriptions

    • Cognitive strategies
      • Techniques to better perceive and understand own thinking and to break through adverse behavior patterns (eg, cognitive reframing and motivational techniques)
    • Positive activities
      • Behavior activation; interaction of body and emotion; and focus on positive things in life, own values and skills
    • Communication and interaction
      • Dealing with feedback, ways to improve communication skills, setting boundaries, and approaching others
    • Mindfulness and imagination
      • Conscious perception and experience of the current moment, acceptance, gratitude, focusing on positive things, and relaxation
    • Metacognitive training
      • Modification of cognitive biases and dysfunctional beliefs and reducing stigmatization and shame
    • Gambling
      • Modification of gambling-specific cognitive distortions, support with financial burdens, and dealing with relapses and gambling impulses
    • My exercises
      • Own exercises can be created
    Textbox 1. Module descriptions of the MCT & More smartphone app.
    ‎
    Figure 2. Screenshots of exercises.
    View this figure

    The contents and exercises are based on group metacognitive training (MCT) [50], cognitive behavioral therapy [51,52], and third wave techniques (eg, acceptance and mindfulness) [53,54]. The metacognitive training (MCT) was originally developed for people with psychosis [50]. Inspired by metacognitive training (MCT), a (group) training specifically for depression has evolved (metacognitive training for depression, D-MCT) [55]. Meta-analyses showed that metacognitive training (MCT) is effective in reducing anxiety, depression, and dysfunctional metacognitions (g=1.81-2.06) [56,57]. The app can be used as an add-on of metacognitive training for depression (D-MCT) but can also be used standalone. Metacognitive training for depression (D-MCT) focuses on the modification of cognitive biases and beliefs associated with the onset and maintenance of mental disorders such as psychosis and depression [50,55]. The training seeks to enable individuals to recognize and correct automatic and unconscious thought patterns. It also targets dysfunctional assumptions about thought processes as well as dysfunctional coping strategies (eg, social withdrawal, thought suppression, and rumination). On the basis of the principle that taking care of personal psychological well-being is a bit like brushing one’s teeth, the exercises should be performed regularly so that they become routine. Therefore, the app sends daily reminders via push messages. In addition, the MCT & More app contains gamification elements. Depending on the number of exercises completed, users can collect bronze, silver, or gold medals and obtain an open umbrella as a symbol for long-term protection. The app also offers the ability to create their own exercises. A learning algorithm, that is, an automatic adaptation to the user’s behavior, was not integrated (the app does not fall under the Medical Devices Act). The app MCT & More is currently available in German, English, Arabic, Turkish, Persian, and Serbian and can be downloaded free of charge for both Android and iOS operating systems.

    The app has been continuously developed (eg, gamification elements, design, program packages gambling and metacognitive training, additional exercises in the other program packages, and various language versions) since the last evaluation [37]. The self-help smartphone app did not undergo major changes during the evaluation process of this study.

    Statistical Analyses

    IBM Statistics 26 was used for statistical analysis. Independent samples t tests and chi-square tests were performed to compute group differences in baseline characteristics. Between-group differences over time (preintervention to postintervention) were calculated using ANCOVA with baseline scores as covariates. Pre-post differences were defined as within-group factors and groups as between-group factors. Paired samples t tests were used to analyze within-group differences. To determine the efficacy of the self-help smartphone app, intention-to-treat (ITT), PP, and complete-case (CC) analyses were performed. In the ITT analyses, all participants for whom baseline data were available were included in the evaluation. Missing data for the postvalues were calculated using expectation maximization. The PP analyses included only those participants who used the intervention as intended (at least once a week) and completed the postassessment. CC analyses included all participants who completed the postassessment (regardless of whether and how often the intervention was used). In the guidelines of the CONSORT (Consolidated Standards of Reporting Trials), it is recommended to perform both ITT and PP analyses in randomized controlled trials. With their conservative approach, ITT analyses comply with the guidelines of Good Clinical Practice and can be considered the gold standard for the evaluation of treatment effects [58,59]. In the PP analyses, the evaluation of the treatment effect is carried out under ideal conditions, so they provide an estimation of the actual efficacy. Furthermore, an explorative moderation analysis was carried out for the PP sample to identify possible moderators (included moderator variables were sociodemographic data, psychometric scales, and medication; Table 1) that affected differential symptom improvement (outcome measure: PHQ-9) using SPSS macro PROCESS by Hayes [60].

    Table 1. Demographic description of the intention-to-treat sample (N=400).
    Baseline characteristicsIntervention group (n=200)Wait-list control group (n=200)Chi-square test (df)t test (df)P value
    Sociodemographic data

    		Male, n (%)24 (12)19 (9.5)1.0 (2)N/Aa.60

    		Age (years), mean (SD)23.13 (3.56)22.84 (3.15)N/A−0.86 (398).39

    		German, n (%)190 (95)194 (97)1.0 (1)N/A.31

    		School education (years), mean (SD)12.39 (1)12.48 (0.92)N/A0.91 (398).37
    Marital status, n (%)1.3 (3)N/A.73

    		Single99 (49.5)94 (47)



    		Relationship95 (47.5)101 (50.5)



    		Married5 (2.5)5 (2.5)



    		Divorced1 (0.5)0 (0)


    Field of study, n (%)5.1 (6)N/A.53

    		Engineering4 (2)3 (1.5)



    		Natural sciences9 (4.5)13 (6.5)



    		Medical science or health61 (30.5)59 (29.5)



    		Legal sciences or economics24 (12)19 (9.5)



    		Linguistics or culture10 (5)6 (3)



    		Social sciences88 (44)90 (45)



    		Others4 (2)10 (5)


    Semester, mean (SD)5.6 (3.63)5.57 (3.57)N/A−1.18 (398).24
    Psychometric scales or psychiatric disorders, n (%)

    		None100 (50)104 (52)0.2 (1)N/A.69

    		Anxiety54 (27)40 (20)2.7 (1)N/A.10

    		Depression72 (36)69 (34.5)0.1 (1)N/A.75

    		PTSDb11 (5.5)11 (5.5)0.0 (1)N/A.99

    		Alcohol or drug addiction7 (3.5)1 (0.5)4.6 (1)N/A.03

    		OCDc5 (2.5)17 (8.5)6.9 (1)N/A.008

    		Eating disorder9 (4.5)9 (4.5)0.00 (1)N/A.99

    		Personality disorder9 (4.5)1 (0.5)6.6 (1)N/A.01

    		ADDd4 (2)2 (1.0)0.7 (1)N/A.41

    		Others5 (2.5)2 (1)0.4 (1)N/A.56
    Medication, n (%)

    		None155 (77.5)157 (78.5)0.1 (1)N/A.81

    		Antidepressants16 (8.0)17 (8.5)0.0 (1)N/A.86
    Measurements, mean (SD)

    		PHQ-9e11.13 (4.99)10.98 (4.42)N/A−0.31 (398).76

    		WHOQOL-BREFf3.64 (0.85)3.7 (0.75)N/A0.69 (398).49

    		RSEg25.73 (6.12)26.62 (5.83)N/A1.49 (398).14

    		APOIh50.27 (7.34)49.92 (8.06)N/A−.46 (398).65

    		PATHEVi35.69 (5.61)36.35 (5.07)N/A1.15 (398).25
    Psychotherapy experiences

    		Previous treatments, n (%)5.3 (3)N/A.15


    		None107 (53.5)109 (54.5)




    		Short-term39 (19.5)49 (24.5)




    		Long-term27 (13.5)28 (14)




    		More than one27 (13.5)14 (7)



    		Assessment, n (%)10.7 (3)N/A.01


    		Positive72 (36)59 (29.5)




    		Neutral23 (11.5)33 (16.5)




    		Negative20 (10)7 (3.5)



    		Others


    		Fear of stigma, n (%)4.5 (3)N/A.21



    		Yes or rather yes127 (63.5)121 (60.5)





    		No73 (36.5)79 (39.5)


    aN/A: not applicable.

    bPTSD: posttraumatic stress disorder.

    cOCD: obsessive-compulsive disorder.

    dADD: attention deficit disorder.

    ePHQ-9: Patient Health Questionnaire-9.

    fWHOQOL-BREF: World Health Organization Quality of Life-abbreviated version.

    gRSE: Rosenberg Self-esteem Scale.

    hAPOI: Attitude Toward Psychological Online Interventions.

    iPATHEV: Patient Questionnaire on Therapy Expectation and Evaluation.


    Sample Characteristics

    A total of 400 participants (intervention group: 200 and wait-list control group: 200) were included in the analyses. Table 1 shows the demographic and psychopathological data of the participants at baseline.

    The overall sample had an average age of 22.98 years (SD 3.36) and consisted of 10.8% (43/400) men and 88.5% (354/400) women. In addition, 0.8% (3/400) of participants stated diverse as their gender. The average PHQ-9 score was 11.1 (SD 4.71; moderate symptoms 10-14). Among the participants, 4.3% (17/400) met the criteria for severe depressive symptoms (PHQ-9 score>19), 20.3% (81/400) for moderately severe depressive symptoms (PHQ-9 score=15-19), 35.8% (143/400) for moderate depressive symptoms (PHQ-9 score=10-14), 32.3% (129/400) for mild depressive symptoms (PHQ-9 score=5-9), and 7.5% (30/400) for minimal depressive symptoms (PHQ-9 score=1-4). In addition, 46% (184/400) of participants stated that they had received psychotherapeutic treatment at least once.

    The randomization was successful (Table 1). There were no significant differences between the groups in terms of age and gender or in primary and secondary outcome parameters (depressive symptoms, self-esteem, and quality of life). There were also no significant differences between the groups in terms of expected treatment outcomes and attitudes toward internet- and mobile-based interventions. However, the intervention group showed a significantly higher number of participants with an alcohol and drug addiction (intervention group: n=7; wait list control group: n=1) as well as a personality disorder (intervention group: n=9; wait list control group: n=1) and a significantly lower number of participants with an obsessive-compulsive disorder (intervention group: n=5; wait list control group: n=17). In addition, participants in the wait-list control group reported a neutral experience with psychotherapy more often (wait list control group: n=33; intervention group: n=23) and a positive experience (wait list control group: n=59; intervention group: n=72) and negative experience (wait list control group: n=7; intervention group: n=20) less often (Table 1).

    Within-Group Differences

    The results of paired samples t tests showed a significant reduction in depressive symptoms, both in the intervention group (t89=4.88; P<.001; d=−0.38) and in the wait-list control group (t134=2.7; P=.007; d=−0.21) from t0 to t1 (Table 2).

    Results of paired samples t tests also indicated a significant increase in scores on the self-esteem scale (RSE) for the intervention group (t89=−6.47; P<.001; d=0.38) and the wait-list control group (t132=−3.46; P=.001; d=0.16). For both groups, the results of the paired samples t test did not show a significant increase in quality of life (WHOQOL-BREF).

    Table 2. Outcome measures at each assessment time for per-protocol sample (used program at least once a week; n=225).
    MeasurementsIntervention group (n=90)Wait-list control group (n=135)
    QuestionnairesPre, mean (SD)Post, mean (SD)Cohen d (95% CI)P valuePre, mean (SD)Post, mean (SD)Cohen d (95% CI)P value
    PHQ-9a11.27 (5.03)9.30 (5.22)b−0.38 (−0.8 to 0.03)<.00111.10 (4.42)10.17 (4.32)c−0.21 (−0.55 to 0.13).007
    RSEb25.56 (6.41)28.00 (6.44)b0.38 (−0.04 to 0.80)<.00126.59 (6.02)27.57 (6.43)b0.16 (−0.18 to 0.50).001
    WHOQOL-BREFc3.74 (0.80)3.86 (0.82)0.15 (−0.27 to 0.65).123.67 (0.76)3.76 (0.72)0.12 (−0.22 to 0.46).19

    aPHQ-9: Patient Health Questionnaire-9.

    bRSE: Rosenberg Self-esteem Scale.

    cWHOQOL-BREF: World Health Organization Quality of Life-abbreviated version.

    Between-Group Differences

    For the primary outcome parameter (depressive symptoms, PHQ-9), the results of the ANCOVA were significant for ITT (F1,398=3.94; P=.048), PP (F1,223=3.98; P=.047), and CC (F1,261=4.60; P=.03; Table 3).

    For reducing depressive symptoms, a small effect size of ηp²=0.018 (d=0.26) was found in the PP sample. Furthermore, the results of the ANCOVA showed statistical significance for the secondary outcome parameter self-esteem (RSE) for ITT (F1,398=6.80; P=.009), PP (F1,221=8.79; P=.003), and CC (F1,259=7.26; P=.008). The analyses resulted in a small to medium effect size for the increase in self-esteem (ηp²=0.038; d=0.40) in the PP sample across time. There was no significant improvement across time in quality of life (WHOQOL-BREF), as analyzed using an ANCOVA with baseline score as covariate in any of the samples: (ITT: F1,398=0.56; P=.46; PP: F1,223=0.41; P=.52; and CC: F1,261=0.81; P=.37).

    Table 3. Analysis of covariances with respective baseline values as covariates.
    MeasurementsCCa (n=263)PPb (n=225)ITTc (n=400)

    		F test (df)P valueηp² F test (df)P value ηp² F test (df)P valueηp²
    PHQ-9d4.60 (1,398).030.0173.98 (1,222).0470.0183.94 (1,261).0480.010
    RSEe7.26 (1,398).0080.0278.79 (1,220).0030.0386.80 (1,259).0090.017
    WHOQOL-BREFf0.81 (1,398).370.0030.41 (1,223).520.0020.56 (1,261).470.001

    aCC: complete-cases.

    bPP: per-protocol.

    cITT: intention-to-treat.

    dPHQ-9: Patient Health Questionnaire-9.

    eRSE: Rosenberg Self-esteem Scale.

    fWHOQOL-BREF: World Health Organization Quality of Life-abbreviated version.

    Study Completion and App Use

    Out of 400 participants, 263 (65.8%) completed the postassessment, 128 (64%) in the intervention group and 135 (67.5%) in the wait-list control group. Regarding study completion, there was no difference between the groups (χ²1=0.5; P=.46). Furthermore, participants who completed the study differed only in terms of their treatment expectations. Participants who completed the study expected a more positive treatment outcome (t0) than participants who did not complete the study (t398=−2.12; P=.04).

    In the intervention group, 60% (120/400) of participants reported how often they used the self-help smartphone app during the intervention period (completed the daily exercise). The self-help smartphone app was used by 23.3% (28/400) of participants daily, by 17.5% (21/400) of participants 4-6 times a week, by 25% (30/400) of participants 2-3 times a week, by 10% (12/400) of participants once a week, by 19.2% (23/400) of participants 1-3 times in total, and by 5% (6/400) of participants not at all. The improvement in symptoms (PHQ-9) did not correlate with use frequency (r=0.020; P=.83). However, use frequency correlated with the expected treatment outcomes (r=0.236; P=.009) and attitude toward internet- and mobile-based interventions (r=0.260; P=.004; 1=not at all to 6=daily). The more positive the attitude toward internet- and mobile-based interventions and the more positive the expected treatment outcomes, the more often the self-help smartphone app was used.

    Attitude and Expectation

    In total, of the 400 participants, 232 (58%) had a positive attitude toward internet- and mobile-based interventions, 30 (7.5%) had a neutral attitude toward internet- and mobile-based interventions, and 138 (34.5%) had a negative attitude toward internet- and mobile-based interventions. Although 87.3% (349/400) of participants believed that internet- and mobile-based interventions are therapeutically effective (optimism regarding personal therapeutic goal clarification, emotional expectation of helpful efficacy, expectation of learning new skills, cognitive acceptance of the methodology), 31.8% (127/400) of participants also stated that they were skeptical about internet- and mobile-based interventions and that they perceived risks (regarding professionalism, side effects, and feasibility). In addition, 67.8% (271/400) of participants perceived difficulties caused by automation (poor crisis management, low learning success, poorer cognitive understanding of therapy contents, and lower motivation because of lack of personal contact). The advantages of anonymity were reported by 45.5% (182/400) of participants (increased discretion, personally increased self-autonomy, reduction of self-stigmatization, and stigmatization by other persons).

    Of the 400 participants, 257 (64.3%) indicated a positive expectation and 117 (29.3%) indicated a negative expectation of treatment outcome regarding the self-help smartphone app. Approximately half of the participants (191/400, 47.8%) did not expect the self-help smartphone app to reduce their symptoms and indicated that this is not the right program for them (172/400, 43%). Only a few participants (38/400, 9.5%) were afraid of change as a result of the self-help smartphone app. The effectiveness of the app could not be predicted by attitudes toward internet- and mobile-based interventions (β=−.006; t275=−0.17; P=.87; R2<0.001; F1,275=0.03; P=.87).

    Side Effects

    Of the 119 participants (intervention group) who completed the questionnaire on side effects (INEP), 51 (42.9%) reported at least one positive side effect. The most commonly reported positive side effect was that participants felt better when using the self-help smartphone app (43/119, 36.1%). Furthermore, 17.6% (21/119) of participants stated that they experienced less pain from events from the past, 14.3% (17/119) stated that they experienced fewer conflicts in their partnership, 13.6% (16/119) stated that they had a better relationship with their friends, 10.9% (13/119) stated that they had a better relationship with their family, and 8.4% (10/119) stated that trusting others was easier for them.

    Overall, of the 119 participants 27 (22.7%) reported a negative side effect. Fear of stigmatization was the most common negative side effect (12/119, 10.1%). In addition, 6.7% (8/119) of participants reported that they had longer phases in which they felt bad, 5.9% (7/119) of participants reported that they had problems with insurance, 5% (6/119) of participants reported that they experienced more pain from events from the past, 1.7% (2/119) of participants reported that they felt worse, 1.7% (2/119) of participants reported that they were more concerned about financial issues, 0.8% (1/119) of participants reported that trusting others is more difficult for them, 0.8% (1/119) of participants reported that they had a worse relationship with their family, and 0.8% (1/119) of participants reported that they had a worse relationship with their friends. None of the participants stated that they had changed as a person to the negative, that they had suicidal thoughts or intentions for the first time, or that they experienced more conflicts in their partnership.

    The most intense change was observed in the improvement (positive side effect; mean 2.62, SD 0.65) and deterioration (negative side effect; mean 3.00, SD 0) of the relationship with the families. In comparison with the negative side effects, positive side effects were mentioned 3 times more frequently (negative: 41/158, 25.9% and positive: 120/158, 75.9%).

    Moderation Analysis

    The results of the interaction effect of the explorative moderation analysis are shown in Table 4.

    The analysis revealed that participants in the intervention group who had a higher expectation of treatment outcome (P=.02; PATHEV total score) and more hope (P=.049; PATHEV hope scale) showed a higher improvement in depressive symptoms (PHQ-9) than the wait-list control group. In addition, participants in the intervention group who were more worried that the app would not help them (P=.03) and participants in the intervention group who stated a higher reduced or excessive need to eat (P=.02) showed a less improved outcome (PHQ-9) than the wait-list control group.

    Table 4. Moderators for Patient Health Questionnaire-9 improvement (dependent variable: Patient Health Questionnaire-9 total difference scores and independent variable: group, means are centered); results of per-protocol sample (N=225).
    ModeratorBa (SE)t test (df)P valueLLCIbULCIcP valued for −1 SDP valued for 0P valued for +1 SD
    PATHEVe total scale0.218 (0.090)2.428 (117).020.0410.396.65.04.002
    PATHEV hope scale0.321 (0.162)1.982 (117).0490.0020.641.90.07.006
    PATHEV item 1−1.023 (0.464)−2.204 (117).03−1.937−0.108.004.14.70
    PHQ-9f item 5−1.058 (0.466)−2.272 (223).02−1.975−0.140.003.01.36

    aB: interaction coefficient.

    bLLCI: lower limit confidence interval.

    cULCI: upper limit confidence interval.

    dThe last 3 columns present the simple slopes.

    ePATHEV: Patient Questionnaire on Therapy Expectation and Evaluation.

    fPHQ-9: Patient Health Questionnaire-9.

    Subjective Appraisal

    In the intervention group, 119 participants completed the questionnaire on patient satisfaction (ZUF-8). Table 5 shows the users’ subjective appraisal for each item.

    The average total score was mean 20.28 (SD 5.36; 8=very dissatisfied to 32=very satisfied). The quality of the self-help smartphone app was rated positively by 64.7% (77/119) of participants. For each item, the positive evaluations outweighed the negative evaluations. In addition to ZUF-8, 3 further questions were asked regarding participant satisfaction. The majority of participants found the language 84.9% (101/119), text length 77.3% (92/119), and number of exercises 49.6% (59/119) in the self-help smartphone app to be just right.

    Table 5. Subjective appraisal using Fragebogen zur Patientenzufriedenheit of MCT & More (n=119).
    ZUF-8a itemMean (SD)Positiveb, n (%)
    1. How do you rate the quality of the program? (excellent, good vs not that good, or not good)c2.29 (0.61)77 (64.7)
    2. Did you receive the type of treatment you expected to receive? (absolutely, a lot vs a little, or not at all)2.45 (0.78)59 (49.6)
    3. To what extent did the program help you cope with your problems? (absolutely, a lot vs a little, or not at all)c2.63 (0.79)56 (47.1)
    4. Would you recommend the program to a friend with similar symptoms? (yes, probably yes vs probably not, or no)2.61 (0.92)52 (43.7)
    5. How happy are you about the extent of the help you have received through using the program? (very satisfied, mostly satisfied vs somewhat dissatisfied, or dissatisfied)2.50 (0.82)66 (55.5)
    6. Did the program help you to cope with your problems more successfully? (absolutely, a lot vs a little, or not at all)c2.39 (0.63)66 (55.5)
    7. How satisfied are you with the program in general? (very satisfied, mostly satisfied vs somewhat unsatisfied, or unsatisfied)c2.42 (0.85)67 (56.3)
    8. Would you use the program again? (Yes, probably yes vs probably not, or no)2.44 (0.92)59 (49.6)

    aZUF-8: Fragebogen zur Patientenzufriedenheit (German version of the Client Satisfaction Questionnaire-8).

    b4-point rating scale: 1 and 2 were rated as negative and 3 and 4 as positive. In the table it is stated how often the question has been answered positively (rated 3 or 4).

    cA lower score indicates a more positive response (inverted scores).


    Principal Findings

    The study demonstrates the effectiveness of the self-help smartphone app MCT & More in students with depressive symptoms. As expected, the app led to a significant reduction in depressive symptoms and a significant increase in self-esteem in the intervention period of 4 weeks. In our study, a small effect size of d=0.26 (PHQ-9; PP sample) in reducing depressive symptoms was found, which is comparable with the effect size found in a meta-analysis of smartphone apps for depressive symptoms (g=0.22) [34] and is slightly higher than the effect size reported in a more recent meta-analysis in which the sample consisted of university students with depressive symptoms (g=0.18) [20]. In addition, a small to medium effect size of d=0.40 (RSE; PP sample) was found for the increase in self-esteem, which corresponds to the findings of a study on a self-help web-based intervention, which was mainly focused on the treatment of depressive symptoms [61]. Contrary to our expectations, the use of the self-help smartphone app did not lead to a significant increase in quality of life (WHOQOL-BREF). The WHOQOL-BREF defines quality of life as the individual perception of one’s own life situation [41]. It is possible that an improvement in the life situation only occurs after a longer period and would have been shown in follow-up examinations [61]. The quality of life was assessed using a single global item. It is possible that improvements would have been found on the subscales of the WHOQOL-BREF (eg, psychological quality of life and social relationships). In the intervention group and the wait-list control group, a significant reduction in depressive symptoms and a significant increase in self-esteem were observed after the intervention period of 4 weeks. Despite the improvements in the wait-list control group, significant group differences were found (significantly higher improvement in the intervention group). The improvement in the wait-list control group may be because of changes in external circumstances, the use of other services, or spontaneous remissions [62]. As the survey took place during the COVID-19 pandemic, depressive symptoms among students may have been more severe than usual [63]. In addition, the quality of life may have been reduced [64].

    Adherence and Acceptance

    Most participants used the self-help smartphone app regularly (91/129, 75.8%) at least once a week; self-assessment) and completed the study (263/400, 65.8%). Participants who completed the postassessment expected a more positive treatment outcome at the baseline assessment than the participants who dropped out of the study (t398=−2.12; P=.04). This result was also found by Mira et al [36] and underlines the relevance of the expected treatment outcome at the beginning of the intervention for participants’ study adherence. The reduction in symptoms (PHQ-9) did not correlate with the frequency of use of the self-help smartphone app. Other researchers who investigated the relationship between frequency of use and symptom reduction also concluded that using apps with a medium frequency only leads to a little additional benefit than using apps with low frequency [65]. It should be considered that the assumption of a linear relationship between frequency of use and symptom reduction might be too simplistic and that further variables need to be evaluated to better understand the relationship. A possible explanation may also be that, because the intervention was not linear or sequential, participants may have been more likely to use only the parts of the intervention they needed. For some, a low dose may have been sufficient for symptom improvement, whereas other users may have required to use the program more often.

    Attitudes and Expectations

    The students’ overall expectation of treatment outcomes and their attitude toward internet- and mobile-based interventions was moderate. Almost half of the students (192/400, 48%) did not expect any improvement from the app, and about one-third of the students (140/400, 35%) had a negative attitude toward internet- and mobile-based interventions. These findings are consistent with the results of another German study, in which 41% of the respondents (patients with depressive symptoms in primary care) indicated a low acceptance of internet- and mobile-based interventions for depression [66]. However, other studies conducted in Germany found a more positive attitude toward internet- and mobile-based interventions for depressive symptoms (total scale: mean 55.86, baseline total scale intervention group: mean 56.13, and baseline total scale control group: mean 55.59) [67,68]. It is possible that the attitude toward internet- and mobile-based interventions was lower in this study (mean 50.09; higher scores indicate a more positive attitude) because of the young age of the sample. In Germany, younger people report a more negative attitude toward internet- and mobile-based interventions than older people [69]. The attitude could possibly be improved by showing information videos that address potential barriers of acceptance (eg, low expectations regarding efficacy and worries about data security) before use [66]. Furthermore, the more positive the attitude toward internet- and mobile-based interventions and the more positive the expectations of the treatment outcome, the more frequently the self-help smartphone app was used, which was also found in other studies [70,71].

    Most of the students trusted the therapeutic efficacy (328/400, 82%), which seems contradictory at first, as about half of the participants (192/400, 48%) did not expect any improvement. It is possible that the participants were generally convinced of the efficacy of internet- and mobile-based interventions (APOI queries a general attitude) but did not expect any improvement for themselves (PATHEV refers to their own symptomatology). Individuals with depressive symptoms often do not believe their symptoms will improve because they often express feelings of hopelessness [72].

    The moderation analysis revealed that participants in the intervention group who indicated a higher expectation of treatment outcome (PATHEV total score) and more hope (PATHEV scale hope) achieved a higher reduction in depressive symptoms (PHQ-9) than those in the wait-list control group. The results of the linear regression showed that the attitude toward internet- and mobile-based interventions did not allow a prediction of the effectiveness. In addition, participants who were more worried that the app would not help them (PATHEV, item 5) showed less improvement in symptoms (PHQ-9). These findings are in contrast with the results of Lüdtke et al [37], who found no impact (moderation analysis) of expected treatment outcome (University of Rhode Island Change Assessment) on symptom reduction. This could be because of the use of different measurements. However, Schröder et al [68] found that participants with a more positive attitude (APOI) at the beginning of an internet intervention experienced a stronger reduction in symptoms than participants with a more negative attitude. Another recent study on the effectiveness of a self-help smartphone app for depression showed that the expected treatment outcome was a predictor of symptom reduction [36].

    Subjective Appraisal

    The majority of the participants were satisfied with the quality of the self-help smartphone app (77/119, 64.7%) and the extent of help (66/119, 55.5%). Another study evaluating a cognitive behavioral therapy–based self-help web-based program among students with depressive symptoms also found a moderate overall satisfaction (study by Santucci et al [73]: total satisfaction score (ZUF-8): mean 21.70 (SD 5.20) and total satisfaction score (ZUF-8) of this study: mean 20.28 (SD 5.36)). In a pilot study of the self-help smartphone app MCT & More, the participants reported a higher overall satisfaction (eg, 88.5% of the participants were satisfied with the quality of the self-help smartphone app [37]). This could be because of the different average ages of the samples (pilot study: 43 years and this study: 23 years). Older age is associated with greater intervention effects [74] and more positive attitudes toward internet-based interventions [69], which may lead to higher satisfaction.

    Strength and Limitations

    No psychiatric diagnosis was required to participate in the study, and participation was possible even with mild depressive symptoms, which led to a heterogeneity of depression levels. This has the advantage that a wider range of individuals with a desire for treatment was reached (regardless of whether they fulfilled the criteria of a diagnosis). On the other hand, it has been shown that individuals with severe depressive symptoms benefit more from low-threshold psychological interventions than mildly depressed individuals [75]. In contrast, a meta-analysis showed that self-guided internet-based interventions are effective regardless of symptom severity [17]. Furthermore, treatment adherence was rather high (91/120, 75.8% used the app at least once a week), which allowed the potential of the app to be well exploited. As the study was conducted on the web, the data collected were based on self-assessments of the participants. Therefore, it could not be eliminated that socially desirable or dishonest statements were made that could have distorted the results. In addition, despite the integrated control questions on studying, it could not be completely prevented that individuals who were not enrolled at a German university also took part in the study. An unambiguous verification of the student status (eg, via enrolment certificates) was not possible because of data privacy reasons. There was no structural equality between the sample and the general population (students in Germany) regarding gender and subject groups [13,76]. The higher proportion of women could be because women are more often affected by depression than men (women: 10.8% and men: 7.6%) and that this difference is particularly evident in young adulthood [77,78]. Furthermore, the study showed baseline differences regarding some comorbid self-reported diagnoses and the evaluation of previous therapy experiences. Nevertheless, randomization was largely considered successful. Follow-up investigations were not possible because of the time frame of the study. For this reason, no conclusions can be drawn regarding the medium- or long-term effects of the self-help smartphone app.

    Conclusions

    The effectiveness of the self-help smartphone app MCT & More was demonstrated in students with depressive symptoms, although the overall outcome expectation and attitude toward internet- and mobile-based interventions were only moderate. Despite the improvements in the wait-list control group, significant group differences were found. The use of the app led to a significantly higher reduction in depressive symptoms (d=0.26) and a significantly higher increase in self-esteem (d=0.40). The expected treatment outcome and the attitude toward internet- and mobile-based interventions were correlated with the frequency of use. The more positive the attitude and the more positive the result expectation, the more frequently the self-help smartphone app was used. Participants who indicated a higher expectation of treatment outcome and more hope achieved a higher reduction in depressive symptoms. In addition, participants who were more worried that the app would not help them and participants who stated a higher reduced or excessive need to eat showed less improvement in symptoms.

    Future studies should investigate further variables (with respect to personal characteristics and app features) that positively influence the effectiveness of identifying ways of increasing efficacy. To make self-help smartphone apps as target group–specific as possible, further subgroups should be identified for which a particularly high or low effectiveness is shown. In addition, follow-up studies are required to determine the long-term effects. It should be investigated how attitudes toward internet- and mobile-based interventions and the expected treatment outcome can be improved to establish effective self-help smartphone apps as low-threshold offers at universities and to promote treatment adherence. The self-help smartphone app could be used regularly at German universities as a low-threshold program to enhance students’ health.

    Conflicts of Interest

    The authors developed the app MCT & More.

    ‎
    Multimedia Appendix 1

    CONSORT-eHEALTH checklist (V 1.6.1).

    PDF File (Adobe PDF File), 479 KB
    1. Auerbach RP, Mortier P, Bruffaerts R, Alonso J, Benjet C, Cuijpers P, WHO WMH-ICS Collaborators. WHO World Mental Health Surveys International College Student Project: Prevalence and distribution of mental disorders. J Abnorm Psychol 2018 Oct;127(7):623-638. [CrossRef] [Medline]
    2. Grützmacher J, Gusy B, Lesener T, Sudheimer S, Willige J. Gesundheit Studierender in Deutschland 2017. Ein Kooperationsprojekt zwischen dem Deutschen Zentrum für Hochschul- und Wissenschaftsforschung, der Freien Universität Berlin und der Techniker Krankenkasse. 2018.   URL: https:/​/www.​tk.de/​resource/​blob/​2050660/​8bd39eab37ee133a2ec47e55e544abe7/​gesundheit-studierender-in-deutschland-2017-studienband-data.​pdf [accessed 2021-06-09]
    3. Richardson T. Is student depression fuelling dropout rates? Trinity News. 2008.   URL: https://researchportal.bath.ac.uk/en/publications/is-student-depression-fuelling-dropout-rates [accessed 2021-06-23]
    4. Middendorff E, Apolinarski B, Becker K, Bornkessel P, Brandt T, Heißenberg S, et al. Die wirtschaftliche und soziale Lage der Studierenden in Deutschland 2016. Bundesministerium für Bildung und Forschung (BMBF). Berlin; 2017.   URL: https://www.bmbf.de/upload_filestore/pub/21._Sozialerhebung_2016_Zusammenfassung.pdf [accessed 2021-06-09]
    5. Meridew C, Athey A, Killgore W, Gehrels J, Alfonso-Miller P, Grandner M. 0190 Academic performance associated with sleep duration among student athletes: impact of insomnia, fatigue, and depression. Sleep 2018;41(suppl_1):74-75. [CrossRef]
    6. Mihăilescu A, Diaconescu L, Ciobanu A, Donisan T, Mihailescu C. The impact of anxiety and depression on academic performance in undergraduate medical students. Eur Psychiatry 2020 Mar 23;33(S1):s284. [CrossRef]
    7. Hunt J, Eisenberg D. Mental health problems and help-seeking behavior among college students. J Adolesc Health 2010 Jan;46(1):3-10. [CrossRef] [Medline]
    8. Andrade LH, Alonso J, Mneimneh Z, Wells JE, Al-Hamzawi A, Borges G, et al. Barriers to mental health treatment: results from the WHO World Mental Health surveys. Psychol Med 2013 Aug 09;44(6):1303-1317. [CrossRef]
    9. Wallin E, Maathz P, Parling T, Hursti T. Self-stigma and the intention to seek psychological help online compared to face-to-face. J Clin Psychol 2018 Jul;74(7):1207-1218. [CrossRef] [Medline]
    10. Clement S, Schauman O, Graham T, Maggioni F, Evans-Lacko S, Bezborodovs N, et al. What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychol Med 2015 Jan;45(1):11-27. [CrossRef] [Medline]
    11. Carey M, Jones K, Meadows G, Sanson-Fisher R, D'Este C, Inder K, et al. Accuracy of general practitioner unassisted detection of depression. Aust N Z J Psychiatry 2014 Jan 10;48(6):571-578 [FREE Full text] [CrossRef] [Medline]
    12. Mohr DC, Ho J, Duffecy J, Baron KG, Lehman KA, Jin L, et al. Perceived barriers to psychological treatments and their relationship to depression. J Clin Psychol 2010 Apr;66(4):394-409 [FREE Full text] [CrossRef] [Medline]
    13. Deutsche Studierende und Studienanfänger/-innen im 1. Hochschulsemester nach Alter, Hochschularten und Geschlecht. Statistisches Bundesamt. 2019.   URL: https://www.datenportal.bmbf.de/portal/de/K254.html [accessed 2021-06-09]
    14. Loecherer R, Apolinário-Hagen J. Wirksamkeit und Akzeptanz von webbasierten Selbsthilfeprogrammen zur Förderung psychischer Gesundheit und zur Stressbewältigung im Studiumin Scoping-Review der aktuellen Forschungsliteratur. e-beratungsjournal. 2017.   URL: https://www.e-beratungsjournal.net/ausgabe_0117/Loecherer_Apolinario-Hagen.pdf [accessed 2021-06-09]
    15. Moessner M, Bauer S. E-mental-health und internetbasierte psychotherapie. Psychotherapeut 2017 May 5;62(3):251-266. [CrossRef]
    16. Karyotaki E, Ebert DD, Donkin L, Riper H, Twisk J, Burger S, et al. Do guided internet-based interventions result in clinically relevant changes for patients with depression? An individual participant data meta-analysis. Clin Psychol Rev 2018 Jul;63:80-92. [CrossRef] [Medline]
    17. Karyotaki E, Riper H, Twisk J, Hoogendoorn A, Kleiboer A, Mira A, et al. Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms: a meta-analysis of individual participant data. JAMA Psychiatry 2017 Apr 01;74(4):351-359. [CrossRef] [Medline]
    18. Sander L, Rausch L, Baumeister H. Effectiveness of Internet-Based Interventions for the Prevention of Mental Disorders: A Systematic Review and Meta-Analysis. JMIR Ment Health 2016 Aug 17;3(3):e38. [CrossRef] [Medline]
    19. Davies EB, Morriss R, Glazebrook C. Computer-delivered and web-based interventions to improve depression, anxiety, and psychological well-being of university students: a systematic review and meta-analysis. J Med Internet Res 2014;16(5):e130 [FREE Full text] [CrossRef] [Medline]
    20. Harrer M, Adam SH, Baumeister H, Cuijpers P, Karyotaki E, Auerbach RP, et al. Internet interventions for mental health in university students: a systematic review and meta-analysis. Int J Methods Psychiatr Res 2019 Jun;28(2):e1759. [CrossRef] [Medline]
    21. Bennett SD, Cuijpers P, Ebert DD, McKenzie Smith M, Coughtrey AE, Heyman I, et al. Practitioner Review: Unguided and guided self-help interventions for common mental health disorders in children and adolescents: a systematic review and meta-analysis. J Child Psychol Psychiatry 2019 Aug;60(8):828-847. [CrossRef] [Medline]
    22. Klein JP, Gerlinger G, Knaevelsrud C, Bohus M, Meisenzahl E, Kersting A, et al. [Internet-based interventions in the treatment of mental disorders : overview, quality criteria, perspectives]. Nervenarzt 2016 Nov 20;87(11):1185-1193. [CrossRef] [Medline]
    23. Hintz S, Frazier PA, Meredith L. Evaluating an online stress management intervention for college students. J Couns Psychol 2015 Apr;62(2):137-147. [CrossRef] [Medline]
    24. Richards D, Timulak L, Hevey D. A comparison of two online cognitive-behavioural interventions for symptoms of depression in a student population: the role of therapist responsiveness. Couns Psychother Res 2013 Sep;13(3):184-193. [CrossRef]
    25. Ataş AH, Çelik B. Smartphone use of university students: patterns, purposes, and situations. Malays Online J Educ Technol 2019 Apr 01;7(2):54-70. [CrossRef]
    26. Lee M, Lee H, Kim Y, Kim J, Cho M, Jang J, et al. Mobile app-based health promotion programs: a systematic review of the literature. Int J Environ Res Public Health 2018 Dec 13;15(12):2838. [CrossRef] [Medline]
    27. Ponzo S, Morelli D, Kawadler JM, Hemmings NR, Bird G, Plans D. Efficacy of the digital therapeutic mobile app biobase to reduce stress and improve mental well-being among university students: randomized controlled trial. JMIR Mhealth Uhealth 2020 Apr 06;8(4):e17767 [FREE Full text] [CrossRef] [Medline]
    28. Bendtsen M, Müssener U, Linderoth C, Thomas K. A mobile health intervention for mental health promotion among university students: randomized controlled trial. JMIR Mhealth Uhealth 2020 Mar 20;8(3):e17208 [FREE Full text] [CrossRef] [Medline]
    29. Andersson G, Titov N. Advantages and limitations of internet-based interventions for common mental disorders. World Psychiatry 2014 Feb;13(1):4-11 [FREE Full text] [CrossRef] [Medline]
    30. Domhardt M, Steubl L, Baumeister H. Internet- and mobile-based interventions for mental and somatic conditions in children and adolescents. Z Kinder Jugendpsychiatr Psychother 2020 Jan;48(1):33-46 [FREE Full text] [CrossRef] [Medline]
    31. Titov N, Dear BF, Johnston L, Lorian C, Zou J, Wootton B, et al. Improving adherence and clinical outcomes in self-guided internet treatment for anxiety and depression: randomised controlled trial. PLoS One 2013;8(7):e62873 [FREE Full text] [CrossRef] [Medline]
    32. Grundy Q, Chiu K, Held F, Continella A, Bero L, Holz R. Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis. Br Med J 2019 Mar 20;364:l920 [FREE Full text] [CrossRef] [Medline]
    33. Terhorst Y, Rathner E, Baumeister H, Sander L. Hilfe aus dem App-Store?: Eine systematische übersichtsarbeit und evaluation von apps zur anwendung bei depressionen. Verhaltenstherapie 2018 May 8;28(2):101-112. [CrossRef]
    34. Firth J, Torous J, Nicholas J, Carney R, Pratap A, Rosenbaum S, et al. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry 2017 Oct;16(3):287-298 [FREE Full text] [CrossRef] [Medline]
    35. Weisel KK, Fuhrmann LM, Berking M, Baumeister H, Cuijpers P, Ebert DD. Standalone smartphone apps for mental health-a systematic review and meta-analysis. NPJ Digit Med 2019;2:118 [FREE Full text] [CrossRef] [Medline]
    36. Mira A, Soler C, Alda M, Baños R, Castilla D, Castro A, et al. Exploring the relationship between the acceptability of an internet-based intervention for depression in primary care and clinical outcomes: secondary analysis of a randomized controlled trial. Front Psychiatry 2019;10:325 [FREE Full text] [CrossRef] [Medline]
    37. Lüdtke T, Pult LK, Schröder J, Moritz S, Bücker L. A randomized controlled trial on a smartphone self-help application (Be Good to Yourself) to reduce depressive symptoms. Psychiatry Res 2018 Nov;269:753-762. [CrossRef] [Medline]
    38. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001 Sep;16(9):606-613 [FREE Full text] [CrossRef] [Medline]
    39. Gräfe K, Zipfel S, Herzog W, Löwe B. Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D)”. Diagnostica 2004 Oct;50(4):171-181. [CrossRef]
    40. Rosenberg M. Society and the Adolescent Self-Image. Princeton, New Jersey: Princeton University Press; 1965:1-340.
    41. Harper A, Power M, WHOQOL-Group X. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998 May;28(3):551-558. [CrossRef] [Medline]
    42. Fu TS, Tuan Y, Yen M, Wu W, Huang C, Chen W, et al. Psychometric properties of the World Health Organization Quality Of Life Assessment-Brief in methadone patients: a validation study in northern Taiwan. Harm Reduct J 2013 Dec 10;10(1):37 [FREE Full text] [CrossRef] [Medline]
    43. Skevington SM, Lotfy M, O'Connell KA, WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004 Mar;13(2):299-310. [CrossRef] [Medline]
    44. Ilić I, Šipetić S, Grujičić J, Mačužić I, Kocić S, Ilić M. Psychometric Properties of the World Health Organization's Quality of Life (WHOQOL-BREF) questionnaire in medical students. Medicina (Kaunas) 2019 Dec 04;55(12):772 [FREE Full text] [CrossRef] [Medline]
    45. Schröder J, Sautier L, Kriston L, Berger T, Meyer B, Späth C, et al. Development of a questionnaire measuring Attitudes towards Psychological Online Interventions-the APOI. J Affect Disord 2015 Nov 15;187:136-141. [CrossRef] [Medline]
    46. Schulte D. Messung der Therapieerwartung und Therapieevaluation von Patienten (PATHEV). Zeitschrift für Klinische Psychologie und Psychotherapie 2005 Jun;34(3):176-187. [CrossRef]
    47. Juergen S, Nübling R. ZUF-8. Fragebogen zur Messung der Patientenzufriedenheit. Diagnostische Verfahren in der Psychotherapie. Göttingen, Germany: Hogrefe; 2002.   URL: https:/​/www.​researchgate.net/​publication/​247161440_ZUF-8_Fragebogen_zur_Messung_der_Patientenzufriedenheit [accessed 2021-06-23]
    48. Kriz D, Nübling R, Steffanowski A, Rieger J, Schmidt J. atientenzufriedenheit in der stationären Rehabilitation:Psychometrische Reanalyse des ZUF-8 auf der Basismultizentrischer Stichproben verschiedener Indikation. Z Med Psychol. 2008.   URL: https:/​/www.​academia.edu/​17331948/​Patientenzufriedenheit_in_der_station%C3%A4ren_ Rehabilitation_Psychometrische_Reanalyse_des_ZUF_8_auf_der_Basis_multizentrischer_Stichproben_ verschiedener_Indikation_Patients_satisfaction_in_inpatient_rehabilitation_Psychometrical_evaluation_of_the_ZUF_8_based_on_a_multicenter_ sample_of_different_i_ [accessed 2021-06-09]
    49. Ladwig I, Rief W, Nestoriuc Y. Welche Risiken und Nebenwirkungen hat Psychotherapie? - Entwicklung des Inventars zur Erfassung Negativer Effekte von Psychotherapie (INEP). Verhaltenstherapie 2014 Oct 30;24(4):252-263. [CrossRef]
    50. Moritz S, Woodward TS. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Curr Opin Psychiatry 2007 Nov;20(6):619-625. [CrossRef] [Medline]
    51. Beck AT. Thinking and depression. II. Theory and therapy. Arch Gen Psychiatry 1964 Jun 01;10(6):561-571. [CrossRef] [Medline]
    52. Ellis A. Rational psychotherapy and individual psychology. J Individ Psychol 1957;13(1):38-44 [FREE Full text]
    53. Hayes S, Strosahl K, Wilson K. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change. New York, United States: The Guilford Press; 1999:1-304.
    54. Segal Z, Williams J, Teasdale J, Kabat-Zinn J. Die achtsamkeitsbasierte kognitive Therapie der Depression in neuer Ansatz zur Rückfallprävention. 2., erweiterte und überarbeitete Auflage mit MP3-CD Ed. Tübingen: dgvt-Verlag; 2015:A.
    55. Jelinek L, Otte C, Arlt S, Hauschildt M. Denkverzerrungen erkennen und korrigieren: Eine Machbarkeitsstudie zum Metakognitiven Training bei Depression (D-MKT). Zeitschrift für Psychiatrie, Psychologie und Psychotherapie 2013 Oct;61(4):247-254. [CrossRef]
    56. Normann N, Morina N. The efficacy of metacognitive therapy: a systematic review and meta-analysis. Front Psychol 2018 Nov 14;9:2211 [FREE Full text] [CrossRef] [Medline]
    57. Normann N, van Emmerik AA, Morina N. The efficacy of metacognitive therapy for anxiety and depression: a meta-analytic review. Depress Anxiety 2014 May;31(5):402-411. [CrossRef] [Medline]
    58. Bhide A, Shah PS, Acharya G. A simplified guide to randomized controlled trials. Acta Obstet Gynecol Scand 2018 Apr 27;97(4):380-387 [FREE Full text] [CrossRef] [Medline]
    59. McCoy CE. Understanding the intention-to-treat principle in randomized controlled trials. West J Emerg Med 2017 Oct;18(6):1075-1078 [FREE Full text] [CrossRef] [Medline]
    60. Hayes A. Introduction to Mediation, Moderation, and Conditional Process Analysis : A Regression-Based Approach. New York, United States: Guilford Press; 2013:1-507.
    61. Crisp D, Griffiths K, Mackinnon A, Bennett K, Christensen H. An online intervention for reducing depressive symptoms: secondary benefits for self-esteem, empowerment and quality of life. Psychiatry Res 2014 Apr 30;216(1):60-66. [CrossRef] [Medline]
    62. Bryman A. Social Research Methods, 4th Edition. Oxfordshire, United Kingdom: Oxford University Press; 2012:1-766.
    63. Bäuerle A, Teufel M, Musche V, Weismüller B, Kohler H, Hetkamp M, et al. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J Public Health (Oxf) 2020 Jul 13:A [FREE Full text] [CrossRef] [Medline]
    64. Riiser K, Helseth S, Haraldstad K, Torbjørnsen A, Richardsen KR. Adolescents' health literacy, health protective measures, and health-related quality of life during the Covid-19 pandemic. PLoS One 2020;15(8):e0238161 [FREE Full text] [CrossRef] [Medline]
    65. Donkin L, Hickie IB, Christensen H, Naismith SL, Neal B, Cockayne NL, et al. Rethinking the dose-response relationship between usage and outcome in an online intervention for depression: randomized controlled trial. J Med Internet Res 2013 Oct;15(10):e231 [FREE Full text] [CrossRef] [Medline]
    66. Ebert DD, Berking M, Cuijpers P, Lehr D, Pörtner M, Baumeister H. Increasing the acceptance of internet-based mental health interventions in primary care patients with depressive symptoms. A randomized controlled trial. J Affect Disord 2015 May 1;176:9-17. [CrossRef] [Medline]
    67. Schröder J, Berger T, Meyer B, Lutz W, Hautzinger M, Späth C, et al. Attitudes towards internet interventions among psychotherapists and individuals with mild to moderate depression symptoms. Cogn Ther Res 2017 Apr 22;41(5):745-756. [CrossRef]
    68. Schröder J, Berger T, Meyer B, Lutz W, Späth C, Michel P, et al. Impact and change of attitudes toward internet interventions within a randomized controlled trial on individuals with depression symptoms. Depress Anxiety 2018 May;35(5):421-430. [CrossRef] [Medline]
    69. Apolinário-Hagen J, Harrer M, Kählke F, Fritsche L, Salewski C, Ebert DD. Public attitudes toward guided internet-based therapies: web-based survey study. JMIR Ment Health 2018 May 15;5(2):e10735 [FREE Full text] [CrossRef] [Medline]
    70. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000 Jul 24;160(14):2101-2107. [CrossRef] [Medline]
    71. Hussein Z, Oon SW, Fikry A. Consumer attitude: does it influencing the intention to use mHealth? Procedia Comput Sci 2017;105:340-344. [CrossRef]
    72. Wolfersdorf M. Depressionen Verstehen Und Bewältigen. Berlin, Heidelberg: Springer Nature; 2011:1-154.
    73. Santucci LC, McHugh RK, Elkins RM, Schechter B, Ross MS, Landa CE, et al. Pilot implementation of computerized cognitive behavioral therapy in a university health setting. Adm Policy Ment Health 2014 Jul;41(4):514-521. [CrossRef] [Medline]
    74. Reins JA, Buntrock C, Zimmermann J, Grund S, Harrer M, Lehr D, et al. Efficacy and Moderators of Internet-Based Interventions in Adults with Subthreshold Depression: An Individual Participant Data Meta-Analysis of Randomized Controlled Trials. Psychother Psychosom 2020 Jun 16:1-13 [FREE Full text] [CrossRef] [Medline]
    75. Bower P, Kontopantelis E, Sutton A, Kendrick T, Richards DA, Gilbody S, et al. Influence of initial severity of depression on effectiveness of low intensity interventions: meta-analysis of individual patient data. Br Med J 2013 Feb 26;346:f540 [FREE Full text] [CrossRef] [Medline]
    76. Studierende und Studienanfänger/-innen im 1. Statistisches Bundesamt. 2020.   URL: https:/​/www.​statistischebibliothek.de/​mir/​servlets/​MCRFileNodeServlet/​DEHeft_derivate_00056740/​2110410207004a.​pdf [accessed 2021-06-09]
    77. Hapke U, Cohrdes C, Nübel J. Depressive Symptomatik im europäischen Vergleich – Ergebnisse des European Health Interview Survey (EHIS) 2. Robert Koch-Institut 2019:12-17. [CrossRef]
    78. Thom J, Kuhnert R, Born S, Hapke U. 12-Monats-Prävalenz der selbstberichteten ärztlich diagnostizierten Depression in Deutschland. Robert Koch Institut 2017:9-15. [CrossRef]

    ‎
    ANCOVA: analysis of covariance
    APOI: Attitude Toward Psychological Online Interventions
    CC: complete-case
    CONSORT: Consolidated Standards of Reporting Trials
    INEP: Inventory for Assessing Negative Effects of Psychotherapy
    ITT: intention-to-treat
    MCT: metacognitive training
    PATHEV: Patient Questionnaire on Therapy Expectation and Evaluation
    PHQ-9: Patient Health Questionnaire-9
    PP: per-protocol
    RSE: Rosenberg Self-esteem Scale
    WHOQOL-BREF: World Health Organization Quality of Life-abbreviated version
    ZUF-8: Fragebogen zur Patientenzufriedenheit (German version of the Client Satisfaction Questionnaire-8)

    Edited by L Buis; submitted 18.12.20; peer-reviewed by P Tonn, A González-Robles, L Farrer; comments to author 16.02.21; revised version received 22.02.21; accepted 15.04.21; published 12.07.21

    Copyright

    ©Alina Bruhns, Thies Lüdtke, Steffen Moritz, Lara Bücker. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 12.07.2021.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.